Impact of Photobiomodulation on T3/T4 Ratio and Quality of Life in Hashimoto Thyroiditis


Ercetin C., Sahbaz N. A., Acar S., Tutal F., Erbil Y.

PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY, cilt.38, sa.7, ss.409-412, 2020 (SCI-Expanded) identifier identifier identifier

Özet

Objective and background: Hashimoto's thyroiditis (HT) is both a B cell- and T cell-mediated, organ-specific autoimmune disease. No current treatment for underlying pathological mechanisms is available for HT and once diagnosed it requires long-term levothyroxine (LT4) treatment in most patients. The aim of our study was to evaluate the effects of photobiomodulation (PBM) on HT patients regarding thyroid functions, thyroid autoantibody levels, and decrease in hormone replacement needs.